AIM ImmunoTech Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Mailing Address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Phone
352-448-7797
Fiscal Year End
1231
EIN
520845822
Financial Overview
FY2025
$8.61M
Total Assets
$15.56M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 424B4 Prospectus for IPO or offering | February 17, 2026 | View on SEC |
| S-1/A IPO registration amendment | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 8-K Current report of material events | February 5, 2026 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Advancing the Phase 2/3 DURAPB clinical trial for pancreatic cancer.
- Focused development of lead drug candidate Ampligen (rintatolimod).
Related Companies
Companies in the same industry (SIC: 2836)
Ginkgo Bioworks Holdings, Inc.
DNA
Biological Products, (No Diagnostic Substances)
MeiraGTx Holdings plc
MGTX
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Lexeo Therapeutics, Inc.
LXEO
Biological Products, (No Diagnostic Substances)
Vir Biotechnology, Inc.
VIR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.